NCT00661115 - To Investigate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction. | Biotech Hunter

Enrollment

173

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions

Erectile Dysfunction

Interventions

DRUG

Levitra (Vardenafil, BAY38-9456)

Vardenafil 10 mg. After a 4 week run-in period, subjects were randomized in order to enroll 3 times more subjects in the vardenafil group than in the placebo group. The duration of the active treatment phase was 12 weeks

DRUG

Placebo

Placebo. After a 4 week run-in period, subjects were randomized in order to enroll 3 times more subjects in the vardenafil group than in the placebo group. The duration of the active treatment phase was 12 weeks

Trial Locations (6)

400007

Mumbai

400022

Mumbai

560010

Bangalore

560054

Bangalore

590010

Belagum

625107

Madurai